Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
A genetic model for colorectal tumorigenesis
1990 • 11,800 citations
Lessons from Hereditary Colorectal Cancer
1996 • 4,900 citations
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
1994 • 3,536 citations
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
1998 • 3,517 citations
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
1995 • 2,857 citations
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
1997 • 2,063 citations
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 • 2,036 citations
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
1998 • 1,902 citations
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
1998 • 1,819 citations
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
1998 • 1,771 citations
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
1998 • 1,728 citations
Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
1996 • 1,033 citations
Differentiation and reversal of malignant changes in colon cancer through PPARγ
1998 • 984 citations
Terminal Differentiation of Human Breast Cancer through PPARγ
1998 • 844 citations
Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
1998 • 807 citations
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
1998 • 652 citations
Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
1998 • 612 citations
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
1998 • 599 citations
Activators of the nuclear receptor PPARγ enhance colon polyp formation
1998 • 585 citations
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
1998 • 549 citations
Transcriptional Activation by Peroxisome Proliferator-activated Receptor γ Is Inhibited by Phosphorylation at a Consensus Mitogen-activated Protein Kinase Site
1997 • 544 citations
Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
1999 • 501 citations
RET Proto-Oncogene in the Development of Human Cancer
1999 • 333 citations
Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells
1998 • 319 citations
Modeling stochastic gene expression: Implications for haploinsufficiency
1998 • 244 citations
Signaling pathways in Ras-mediated tumorigenicity and metastasis
1998 • 194 citations
Allelic imbalance, including deletion ofPTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with cowden syndrome and germlinePTEN mutation
1998 • 97 citations
Cited By (0)
No citing papers found in database